O'Day, S., Perez, C., Wise-Draper, T., Hanna, G., Bhatia, S., Kelly, C., Medina, T., Laux, D., Daud, A., Chandra, S., Shaheen, M., Gao, L., Burgess, M., Hernandez-Aya, L., Yeung, C., Smythe, K., DeGoma, E., Daniel, W., Feltner, D., Sindelar, L., Michel, R., Bexon, A., Bexon, M., & Milhem, M. (n.d.). 423 Safety and preliminary efficacy of intratumoral cavrotolimod (AST-008), a spherical nucleic acid TLR9 agonist, in combination with pembrolizumab in patients with advanced solid tumors. Journal for immunotherapy of cancer, 8, A257–A258. http://access.bl.uk/ark:/81055/vdc_100144724074.0x000007